mazindol has been researched along with Cardiometabolic Syndrome in 2 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Because obesity is highly stigmatized, any effective treatment should be made available to improve quality of life and self-image." | 2.47 | Pharmacology in health foods:merits and demerits of food with health claims for the prevention of metabolic syndrome. ( Sakane, N, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakane, N | 1 |
| Mori, Y | 1 |
2 reviews available for mazindol and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Pharmacology in health foods:merits and demerits of food with health claims for the prevention of metabolic syndrome.
Topics: Anti-Obesity Agents; Consumer Health Information; Food, Organic; Humans; Japan; Mazindol; Metabolic | 2011 |
[Mazindol].
Topics: Appetite Depressants; Humans; Mazindol; Metabolic Syndrome; Obesity | 2011 |